These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7184034

  • 1. Nutritional iron and dopamine binding sites in the rat brain.
    Ashkenazi R, Ben-Shachar D, Youdim MB.
    Pharmacol Biochem Behav; 1982; 17 Suppl 1():43-7. PubMed ID: 7184034
    [Abstract] [Full Text] [Related]

  • 2. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    Ben-Shachar D, Pinhassi B, Youdim MB.
    Eur J Pharmacol; 1991 Sep 17; 202(2):177-83. PubMed ID: 1687031
    [Abstract] [Full Text] [Related]

  • 3. Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats.
    Ben-Shachar D, Ashkenazi R, Youdim MB.
    Int J Dev Neurosci; 1986 Sep 17; 4(1):81-8. PubMed ID: 2844061
    [Abstract] [Full Text] [Related]

  • 4. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
    Ben-Shachar D, Youdim MB.
    J Neurochem; 1990 Apr 17; 54(4):1136-41. PubMed ID: 1968955
    [Abstract] [Full Text] [Related]

  • 5. Effect of iron chelators on dopamine D2 receptors.
    Ben-Shachar D, Finberg JP, Youdim MB.
    J Neurochem; 1985 Oct 17; 45(4):999-1005. PubMed ID: 2993525
    [Abstract] [Full Text] [Related]

  • 6. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 17; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 7. Brain iron and dopamine receptor function.
    Youdim MB, Ben-Shachar D, Ashkenazi R, Yehuda S.
    Adv Biochem Psychopharmacol; 1983 Mar 17; 37():309-21. PubMed ID: 6138953
    [Abstract] [Full Text] [Related]

  • 8. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP, Long JP, Williams M, Goodale DB, Mott J, Lakoski JM, Gebhart GF.
    J Pharmacol Exp Ther; 1983 Jan 17; 224(1):161-70. PubMed ID: 6401334
    [Abstract] [Full Text] [Related]

  • 9. Brain iron: a lesson from animal models.
    Yehuda S, Youdim MB.
    Am J Clin Nutr; 1989 Sep 17; 50(3 Suppl):618-25; discussion 625-9. PubMed ID: 2570524
    [Abstract] [Full Text] [Related]

  • 10. Iron deficiency alters discrete proteins in rat caudate nucleus and nucleus accumbens.
    Youdim MB, Sills MA, Heydorn WE, Creed GJ, Jacobowitz DM.
    J Neurochem; 1986 Sep 17; 47(3):794-9. PubMed ID: 2942640
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE, Haubrich DR, Williams M.
    Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920
    [Abstract] [Full Text] [Related]

  • 12. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
    Spyraki C, Fibiger HC.
    Eur J Pharmacol; 1981 Sep 11; 74(2-3):195-206. PubMed ID: 7198991
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE.
    Brain Res; 1982 Jan 28; 232(2):401-12. PubMed ID: 6322915
    [Abstract] [Full Text] [Related]

  • 14. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N, Nakahiro M, Fukuchi I, Saito K, Yoshida H.
    Brain Res; 1985 May 06; 333(2):231-6. PubMed ID: 3158374
    [Abstract] [Full Text] [Related]

  • 15. Possible involvement of pertussis toxin-sensitive G proteins and D2 dopamine receptors in the A1 adenosine receptor-adenylate cyclase system in rat cerebral cortex.
    Murayama T, Itahashi Y, Nomura Y.
    J Neurochem; 1990 Nov 06; 55(5):1631-8. PubMed ID: 2145396
    [Abstract] [Full Text] [Related]

  • 16. Long-lasting dopamine receptor up-regulation in amphetamine-treated rats following amphetamine neurotoxicity.
    Fields JZ, Wichlinski L, Drucker GE, Engh K, Gordon JH.
    Pharmacol Biochem Behav; 1991 Dec 06; 40(4):881-6. PubMed ID: 1816575
    [Abstract] [Full Text] [Related]

  • 17. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Dec 06; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E, Tonello C, Imhof R, Scherschlicht R, da Prada M, Carruba MO.
    J Pharmacol Exp Ther; 1993 Jul 06; 266(1):97-105. PubMed ID: 8101225
    [Abstract] [Full Text] [Related]

  • 19. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA, Kim H, Marshall JF.
    J Pharmacol Exp Ther; 1985 May 06; 233(2):527-38. PubMed ID: 3889277
    [Abstract] [Full Text] [Related]

  • 20. Antipsychotic substances and dopamine in the rat brain; behavioral studies reveal distinct dopamine receptor systems.
    Van Ree JM, Elands J, Király I, Wolterink G.
    Eur J Pharmacol; 1989 Aug 03; 166(3):441-52. PubMed ID: 2572429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.